Search research articles
Contact Us
Filters
Showing results (151-160 of 209) with videos related to
Page
of 21
Sort By:
Journal of Crohn'S & Colitis
|
November 15, 2017
The Proton-activated Receptor GPR4 Modulates Intestinal Inflammation
Yu Wang, Cheryl de Vallière, Pedro H Imenez Silva, et al.
Cell Death & Disease
|
August 19, 2016
Bcl-xL is an oncogenic driver in colorectal cancer
Anna-Lena Scherr, Georg Gdynia, Mariam Salou, et al.
Hepatology (Baltimore, Md.)
|
February 5, 2016
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype
Matthias S Matter, Jens U Marquardt, Jesper B Andersen, et al.
Emerging Infectious Diseases
|
April 30, 2025
Comprehensive Survival Analysis of Alveolar Echinococcosis Patients, University Hospital Zurich, Zurich, Switzerland, 1973-2022
Ansgar Deibel, Yanick Kindler, Rubens Mita, et al.
The American Journal of Surgical Pathology
|
November 18, 2008
Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia
Martin Anlauf, Juliane Bauersfeld, Andreas Raffel, et al.
Gut
|
September 21, 2011
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
Valerie Chew, Jinmiao Chen, Deming Lee, et al.
Cell Reports
|
August 27, 2013
RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation
Mihael Vucur, Florian Reisinger, Jérémie Gautheron, et al.
Nature Immunology
|
October 27, 2015
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
Shlomi Finkin, Detian Yuan, Ilan Stein, et al.
Hepatology (Baltimore, Md.)
|
August 13, 2017
Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2<sup>-/-</sup> ) mice
Anja Moncsek, Mohammed S Al-Suraih, Christy E Trussoni, et al.
Cancer Research
|
April 6, 2006
ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions
Christian Spangenberg, Ekkehart U Lausch, Tatjana M Trost, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 209) with videos related to
Sort By:
Page
of 21
Journal of Crohn'S & Colitis
|
November 15, 2017
The Proton-activated Receptor GPR4 Modulates Intestinal Inflammation
Yu Wang, Cheryl de Vallière, Pedro H Imenez Silva, et al.
Cell Death & Disease
|
August 19, 2016
Bcl-xL is an oncogenic driver in colorectal cancer
Anna-Lena Scherr, Georg Gdynia, Mariam Salou, et al.
Hepatology (Baltimore, Md.)
|
February 5, 2016
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype
Matthias S Matter, Jens U Marquardt, Jesper B Andersen, et al.
Emerging Infectious Diseases
|
April 30, 2025
Comprehensive Survival Analysis of Alveolar Echinococcosis Patients, University Hospital Zurich, Zurich, Switzerland, 1973-2022
Ansgar Deibel, Yanick Kindler, Rubens Mita, et al.
The American Journal of Surgical Pathology
|
November 18, 2008
Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia
Martin Anlauf, Juliane Bauersfeld, Andreas Raffel, et al.
Gut
|
September 21, 2011
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
Valerie Chew, Jinmiao Chen, Deming Lee, et al.
Cell Reports
|
August 27, 2013
RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation
Mihael Vucur, Florian Reisinger, Jérémie Gautheron, et al.
Nature Immunology
|
October 27, 2015
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
Shlomi Finkin, Detian Yuan, Ilan Stein, et al.
Hepatology (Baltimore, Md.)
|
August 13, 2017
Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2<sup>-/-</sup> ) mice
Anja Moncsek, Mohammed S Al-Suraih, Christy E Trussoni, et al.
Cancer Research
|
April 6, 2006
ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions
Christian Spangenberg, Ekkehart U Lausch, Tatjana M Trost, et al.
Page
of 21